SEC Form 4 · accession 0001179110-17-012749
ABBOTT LABORATORIES · ABT
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Daniel Gesua Sive Salvadori
Officer — Senior Vice President
Period of report
Sep 26, 2017
Accepted (ET)
Sep 28, 2017 · 5:13 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0000001800
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common shares without par value | Sep 26, 2017 | M | 34,141 | $42.08 | A | 113,426 | D | |
| Common shares without par value | Sep 26, 2017 | M | 28,319 | $47.00 | A | 141,745 | D | |
| Common shares without par value | Sep 26, 2017 | S | 62,460 | $52.95 | D | 79,285 | D | |
| Common shares without par value | Sep 26, 2017 | F | 5,487 | $52.61 | D | 73,798 | D |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Option (right to buy)F1 | $42.08 | Sep 26, 2017 | M | 34,141 | D | Sep 26, 2017 | Sep 25, 2024 | Common shares | 34,141 | 68,284 | D |
| Option (right to buy)F1 | $47.00 | Sep 26, 2017 | M | 28,319 | D | Feb 20, 2017 | Feb 19, 2025 | Common shares | 28,319 | 99,117 | D |
Explanation of responses
- F1Employee stock option granted pursuant to the Abbott Laboratories 2009 Incentive Stock Program, in a transaction exempt from Section 16 under Rule 16b-3.
Remarks
The exercise and sale transactions were made pursuant to a previously adopted plan complying with Rule 10b5-1(c).